Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0281 Transporter Info
Gene Name	SLC32A1
Transporter Name	Vesicular inhibitory amino acid transporter
Gene ID	140679
UniProt ID	Q9H598

Post-Translational Modification of This DT
Overview of SLC32A1 Modification Sites with Functional and Structural Information
Sequence	M A T L L R S K L S N V A T S V S N K S Q A K M S G M F A R M G F Q A A T D E E A V G F A H C D D L D F E H R Q G L Q M D I L K A E G E P C G D E G A E A P V E G D I H Y Q R G S G A P L P P S G S K D Q V G G G G E F G G H D K P K I T A W E A G W N V T N A I Q G M F V L G L P Y A I L H G G Y L G L F L I I F A A V V C C Y T G K I L I A C L Y E E N E D G E V V R V R D S Y V A I A N A C C A P R F P T L G G R V V N V A Q I I E L V M T C I L Y V V V S G N L M Y N S F P G L P V S Q K S W S I I A T A V L L P C A F L K N L K A V S K F S L L C T L A H F V I N I L V I A Y C L S R A R D W A W E K V K F Y I D V K K F P I S I G I I V F S Y T S Q I F L P S L E G N M Q Q P S E F H C M M N W T H I A A C V L K G L F A L V A Y L T W A D E T K E V I T D N L P G S I R A V V N I F L V A K A L L S Y P L P F F A A V E V L E K S L F Q E G S R A F F P A C Y S G D G R L K S W G L T L R C A L V V F T L L M A I Y V P H F A L L M G L T G S L T G A G L C F L L P S L F H L R L L W R K L L W H Q V F F D V A I F V I G G I C S V S G F V H S L E G L I E A Y R T N A E D
PTM type	X-N-glycosylation X-O-glycosylation X-Oxidation X-Phosphorylation X: Amino Acid

N-glycosylation
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC32A1			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	341
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC32A1 Asparagine 341 has the potential to affect its expression or activity.
O-glycosylation
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC32A1			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	15
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC32A1 Serine 15 has the potential to affect its expression or activity.
Oxidation
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC32A1			[4]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	47
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC32A1 Cystine 47 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC32A1			[4]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	169
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC32A1 Cystine 169 has the potential to affect its expression or activity.
Phosphorylation
Serine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC32A1			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	96
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC32A1 Serine 96 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC32A1			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	98
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC32A1 Serine 98 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: VIAAT_HUMAN)
2	A triarylphosphine-trimethylpiperidine reagent for the one-step derivatization and enrichment of protein post-translational modifications and identification by mass spectrometry. Chem Commun (Camb). 2018 Dec 6;54(98):13790-13793.
3	Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer's disease. J Pathol. 2017 Sep;243(1):78-88.
4	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
5	Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics. 2015 Jan;15(2-3):508-519.
6	Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome. Proteomics. 2015 Jan;15(2-3):500-7.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence